Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+26.96%
+1.46%
+15.31%
+1.40%
Most Trending
+26.96%
+1.46%
+15.31%
+1.40%
bullish.beatsStreaking.Winners tracks stocks achieving consecutive gains, focusing on consistent performers and market momentum to keep investors informed.
09 Nov 2025$EQT has been on an impressive streak seven straight sessions of gains that signal renewed investor confidence in the energy space. The move reflects both improving fundamentals in the natural gas market and a shift toward more disciplined capital allocation. EQT steady uptrend shows traders are quietly accumulating, though energy names remain vulnerable to commodity price swings.
$APA is showing life again. While the name surfaced in connection with openvelas inaugural AIoT conference a project tied to open-source development under Apache licensing the real story is in the technical recovery of the stock. It’s attracting speculative interest as energy sentiment improves, but volatility and dependence on crude prices remain its biggest risks.
$TERN Terns Pharmaceuticals, is another stock that’s caught fire, rising seven days in a row as enthusiasm builds around its clinical progress. The biotech recent momentum points to growing optimism in its development pipeline. However, as with most small cap biotech, the same momentum that fuels gains can reverse quickly if data or trial updates disappoint.
$AMX America Movil continues to trade like a textbook example of an overlooked value play. Despite its size and reach across Latin America, the telecom giant is still viewed as undervalued following strong Q3 results. The lack of attention has created a window for accumulation, but macro and currency risks in emerging markets could temper the pace of its upside.
$GLUE Monte Rosa Therapeutics recently received a reaffirmation from Wells Fargo with an Equal-Weight rating and an analyst forecast projecting over 38% potential upside. Despite the cautious coverage, the technical trend remains constructive. With a small-cap profile and strengthening sentiment, GLUE sits squarely in that sweet spot between institutional indifference and retail discovery. The risk lies in biotech volatility, but the setup hints that smart money may already be rotating in.
$EGAN eGain Corporation, recently spiked 6% on higher-than-usual volume a rare move for this relatively quiet AI-driven software player. The question now is whether the rally has legs. Analysts are cautious on near-term earnings revisions, but eGain improving chart and modest valuation give it room to surprise.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
